Yes, " CCL5 and CCR5 were regarded as poor prog
Post# of 145230
" CCL5 and CCR5 were regarded as poor prognosis signature marker in various cancer types "
And thanks to Dr Pestell , who most probably will have Nobel Price one day for his work in CCR5 , .. and Dr NP with his hard work to bring Leronlimab to what it is today .....we will accomplish something very positive soon here for those patients .....
IMO of course....
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)